Michael S. Wyzga - Director at Mereo BioPharma Group plc

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Michael S. Wyzga since 26 Aug 2025

Reported holdings for Michael S. Wyzga in Mereo BioPharma Group plc

Form 4 holding Director

Mereo BioPharma Group plc

Security class
Share Options (Right to buy)
Shares / value
66,000
Estimated value
$55,550
Report date
26 Feb 2026
Price
$1.01
Ownership
Direct
Underlying class
American Depositary Shares
Underlying amount

Transaction history for Michael S. Wyzga in Mereo BioPharma Group plc

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .